Non-event weeks will no longer be a bore in Pokémon GO, as the Choose Your Path Timed Research will let Trainers experience the game in the way they want! Through the Choose Your Path Timed Research, ...

The latest Patch Tuesday update for Windows 11 is among the heaviest in recent memory, bringing a new low-latency mode for smoother system navigation in addition to new features and hundreds of bug ...

Threat actors have begun exploiting a high-severity vulnerability in the popular low-code AI development platform Langflow, according to VulnCheck. Tracked as CVE-2026-5027 (CVSS score of 8.8), the ...

The Pentagon added a slew of Chinese tech firms, including Alibaba and Baidu, to a list of entities it believes to have aided Chinese military. The Defense Department will be prohibited from ...

For the quickest way to join, simply enter your email below and get access. We will send a confirmation and sign you up to our newsletter to keep you updated on all your gaming news.

As Apple WWDC 2026 approaches, the excitement is building around what Apple has in store for us this year. From Siri’s overhaul to new Apple Intelligence updates, there’s a lot to look forward to. The ...

Jake Peterson is Lifehacker’s Tech Editor, and has been covering tech news and how-tos for nearly a decade. His team covers all things technology, including AI, smartphones, computers, game consoles, ...

Microsoft has announced that Visual Studio Code (VS Code) will apply a two-hour delay before extensions for the integrated development environment (IDE) are updated automatically to a newer version in ...

President Donald Trump said only the U.S. and China can retrieve enriched uranium from Iran’s buried nuclear sites after they were 'obliterated' by strikes last year. Trump added he would be willing ...

Google is shutting down its AI-powered Pixel Studio app less than two years after its debut and instead pushing users over to Gemini and Nano Banana for image generation. The update, which appears to ...

Please provide your email address to receive an email when new articles are posted on . Guselkumab showed the ability to inhibit structural damage in adults with active PsA in the APEX trial. The FDA ...